Promoting CT Engagement for Pancreatic Cancer With App

Part of paid clinical trials in Chapel Hill, North Carolina.

Sponsor
UNC Lineberger Comprehensive Cancer Center
Study ID
NCT06252545
Status
Recruiting
Apply to this trial

Conditions

  • Pancreas Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • semistructured interviews — BEHAVIORAL
    Black subjects with pancreatic cancer will provide insight on their experience discussing clinical trials and preferences for communicating clinical trial information
  • feedback — BEHAVIORAL
    Black subjects with pancreatic cancer will provide feedback on mHealth app prototype.

Study Details

To develop a culturally tailored informational mobile application and test whether it will increase participation among Black pancreatic cancer subjects in clinical trial discussions with their care team. This project aims to identify and address barriers to enrollment of Black subjects in pancreatic cancer clinical trials using a culturally informed mobile health application to promote participation. The clinical trial education and communication needs of Black people with pancreatic cancer will be determined. A new mHealth application for clinical trial education and communication tailored to subject needs will be developed. It was hypothesized that a culturally tailored informational mobile application will increase the participation of Black subjects in clinical trial discussions with their care team among the target population. This study focuses on Black pancreatic cancer subjects, who experience higher mortality rates and lower clinical trial participation than White subjects. Research shows that the disparity between clinical trial participation is in part due to inequitable recruitment practices. This study will use mobile application technology (mHealth app) as an educational, communication, audit, and feedback tool to promote patient-initiated clinical trial discussions among Black people with pancreatic cancer and their cancer care team.

Key Dates

Start date
Feb 2, 2024
Status verified
May 2026
Primary completion
Feb 1, 2027
Completion
Feb 1, 2027

Study Design

Enrollment
26 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Other: Interview Group
    Subjects with pancreatic carcinoma who joined the interview group.
  • Other: User Testing Group
    Subjects with pancreatic carcinoma who joined the user testing group

Primary Outcome Measure

The clinical trial education and communication needs [ Time Frame: Up to 1 month ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
UNC Lineberger Comprehensive Cancer CenterChapel HillNorth Carolina27599
Lori Stravers
[email protected]
919-966-4432
Maddy Ledenyi
[email protected]
+1 919-843-4699
Jen Jen Yeh, MD (PRINCIPAL_INVESTIGATOR)
Medical College Of WisconsinMilwaukeeWisconsin53226
Christian Campbell
[email protected]
+1 414-955-1423
Ugwuji Maduekwe, MD, MMSc, MPH (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chapel Hill, NC

By research site
UNC Lineberger Comprehensive Cancer Center· Chapel Hill, NCMedical College Of Wisconsin· Milwaukee, WI

Related Studies